Cargando…
Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
Cancer vaccines are emerging as a viable strategy for cancer treatment. In the current study, we screened for genes associated with the prognosis of patients with lung adenocarcinoma and positively correlated with antigen-presenting cell infiltration and identified KLRG1 and CBFA2T3 as potential tum...
Autores principales: | Xu, Ran, Lu, Tong, Zhao, JiaYing, Wang, Jun, Peng, Bo, Zhang, LinYou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899518/ https://www.ncbi.nlm.nih.gov/pubmed/35265614 http://dx.doi.org/10.3389/fcell.2022.815596 |
Ejemplares similares
-
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
por: Liu, Cong, et al.
Publicado: (2022) -
Identification of tumor antigens and immune subtypes in lung squamous cell carcinoma for mRNA vaccine development
por: Zhao, Jiaying, et al.
Publicado: (2022) -
Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development
por: Chen, Yan, et al.
Publicado: (2022) -
Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021) -
Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma
por: Zhang, Shichao, et al.
Publicado: (2022)